We are a technology start-up from the Faculty of Medicine, Kyoto University, and we are developing a business for the world’s first societal implementation of personalized cancer medicine. We perform drug sensitivity testing on cancer stem cell spheroids selectively cultured from patient cancer tissue, allowing us to select the optimal anticancer drug for each patient’s pathological condition, which is currently not possible with standard chemotherapy. Our goal is to contribute to local healthcare by developing diagnostic services for personalized cancer care in areas where standard chemotherapy for cancer treatment has not been fully established.

---

Area of Interest

• Central and South America
• Africa
• South Asia
• Southeast Asia
• China
• East Asia (excluding China)
• Oceania

---

Site-visit

Not allowed

---

SDGs we are working on

---

Registered Keyword